Current Edition

drug development

Overview: Pharmacovigilance and Risk Management

Drug development is an expensive, lengthy, and high-risk business taking 1015 years and is associated with a high attrition rate. Approximately only 1 in 10 …

Continue Reading →
clinical research

Emmes Standardises on Veeva Development Cloud to Streamline Product Development

Global CRO builds technology foundation to drive scalability, efficiency, and compliance PLEASANTON, CA — Sept. 16, 2021 — Veeva Systems (NYSE: VEEV) today announced that Emmes is standardizing …

Continue Reading →
adverse events

Critical Considerations for Clinical Trial Safety Reporting Investments

Naturally, safety event reporting and pharmacovigilance (PV) should be subject to detailed regulatory scrutiny as evidenced by the Food and Drug Administration (FDA) overseeing the …

Continue Reading →